Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Lung Cancer Clinical Trials

A listing of Lung Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1542) clinical trials

For more information please visit: http://clinicaltrials.gov/ct2/show/record/NCT00632853?term=30610&rank=1

Phase

For more information please visit: http://clinicaltrials.gov/ct2/show/NCT01434342?term=CCCWFU+99211&rank=1

Phase N/A

Study to evaluate the long-term safety and efficacy of Darbepoetin Alfa in anemic subjects with Advanced Stage Non-small Cell Lung Cancer receiving multi-cycle chemotherapy. Patient Inclusion Criteria: Subjects with metastatic (stage IV) Non-small Cell Lung cancer, receiving or about receive first line cyclic chemotherapy, life expectancy >6 months, 18 years ...

Phase

Patients with non-small cell lung cancer who have failed two or more prior treatment regimens, to determine overall survival Patient Inclusion Criteria: 18+ years of age, confirmed stage IIIB or non-small cell lung cancer, failed at least 2 prior systemic anti-cancer regimens, disease progression, Patient Exclusion Criteria: Presence of brain ...

Phase

First-line treatment for patients with non-squamous non-small cell lung cancer Patient Inclusion Criteria: Confirmed diagnosis, at least one measurable target lesion, 18+ years of age, life expectancy of >12 weeks Patient Exclusion Criteria: Small cell or carcinoid lung cancer patients are ineligible, untreated brain metastases, history of active malignancy in ...

Phase

First-line induction and maintenance therapy for the treatment of patients with Stage IV NSCLC Patient Inclusion Criteria: Must have a histologic or cytologic diagnosis of advance NSCLC, may not have received any prior systemic chemotherapy, 18 + years of age Patient Exclusion Criteria: Have a known central nervous system disease, ...

Phase

People with Non-squamous Non-small Cell Lung Cancer (NSCLC) may be eligible to participate in a research study being conducted by Northwell Health.

Phase N/A

A Randomized Phase 2 Trial of AM0010 in Combination With Nivolumab vs. Nivolumab Alone as Second-Line Therapy in Subjects With Stage IV / Metastatic Wild Type Non-Small Cell Lung Cancer and Low Tumor Expression of PD-L1

Phase

People with non-small cell lung cancer are asked to participate in a research study being conducted by Montefiore Medical Center. For Study Information, search for “SPI-POZ-202” on Clinicaltrials.gov  or visit https://clinicaltrials.gov/ct2/show/NCT03318939?term=spi-poz-202&rank=1

Phase N/A

The purpose of this study is to determine the safety, tolerability, and efficacy of epacadostat when given in combination with nivolumab and ipilimumab, and in combination with nivolumab and lirilumab, in subjects with advanced or metastatic malignancies.

Phase N/A